The relationship between baseline disease status and magnitude of placebo course was found to be highly significant ( Fig. 3 ), warranting its addition into the model. 3.5 Final model The placebo submodel with structural, covariate, and residual error components of the model was used as a reference model to test the effect of bapineuzumab treatment.
← all excerpts
Alzheimer's disease assessment scale-cognitive 11-item progression model in mild-to-moderate Alzheimer's disease trials of bapineuzumab.
1
—
—